Authors:
Happich, D
Madlener, K
Schwaab, R
Hanfland, P
Potzsch, B
Citation: D. Happich et al., Application of the TaqMan-PCR for genotyping of the prothrombin G20210A mutation and of the thermolabile methylenetetrahydrofolate reductase mutation, THROMB HAEM, 84(1), 2000, pp. 144-145
Citation: B. Potzsch et al., Use of heparin during cardiopulmonary bypass in patients with a history ofheparin-induced thrombocytopenia, N ENG J MED, 343(7), 2000, pp. 515-515
Authors:
Stolz, E
Kemkes-Matthes, B
Potzsch, B
Hahn, M
Kraus, J
Wirbartz, A
Kaps, M
Citation: E. Stolz et al., Screening for thrombophilic risk factors among 25 German patients with cerebral venous thrombosis, ACT NEUR SC, 102(1), 2000, pp. 31-36
Authors:
Eichler, P
Budde, U
Haas, S
Kroll, H
Loreth, RM
Meyer, O
Potzsch, B
Schabel, A
Albrecht, D
Greinacher, A
Citation: P. Eichler et al., First workshop for detection of heparin-induced antibodies: Validation of the heparin-induced platelet-activation test (HIPA) in comparison with a PF4/heparin ELISA, THROMB HAEM, 81(4), 1999, pp. 625-629
Authors:
Greinacher, A
Volpel, H
Janssens, U
Hach-Wunderle, V
Kemkes-Matthes, B
Eichler, P
Mueller-Velten, HG
Potzsch, B
Citation: A. Greinacher et al., Recombinant hirudin (Lepirndin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia - A prospective study, CIRCULATION, 99(1), 1999, pp. 73-80
Authors:
Greinacher, A
Janssens, U
Berg, G
Bock, M
Kwasny, H
Kemkes-Matthes, B
Eichler, P
Volpel, H
Potzsch, B
Luz, M
Citation: A. Greinacher et al., Lepirudin (recombinant hirudin) for parenteral anticoagulation in patientswith heparin-induced thrombocytopenia, CIRCULATION, 100(6), 1999, pp. 587-593